US Stock MarketDetailed Quotes

ABVC ABVC BioPharma

Watchlist

0.6873
+0.0273+4.14%

Close Sep 27 16:00 ET

0.6877
+0.0004+0.06%

Post 20:01 ET

8.54MMarket Cap-414P/E (TTM)

ABVC BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-12.70%-1.01M

68.41%-473.16K

42.75%-4.24M

-3.99%-479.46K

-164.53%-1.36M

73.76%-899.83K

49.98%-1.5M

2.62%-7.4M

81.74%-461.07K

76.82%-513.7K

Net income from continuing operations

45.03%-1.27M

-109.83%-3.98M

33.12%-10.91M

26.02%-3.33M

10.82%-3.37M

-18.89%-2.32M

68.83%-1.9M

-35.53%-16.31M

34.78%-4.5M

-100.21%-3.78M

Operating gains losses

----

--221.89K

----

Depreciation and amortization

90.15%13.31K

-80.19%1.29K

19.88%28.53K

17.82%7.58K

15.43%7.46K

27.43%7K

20.00%6.49K

98.44%23.8K

96.91%6.44K

126.26%6.46K

Deferred tax

----

-86.62%115.67K

-83.11%151.39K

-184.55%-117.41K

----

4.93%864.8K

-11.39%896.05K

283.53%138.87K

Other non cash items

95.91%243.53K

44,282.51%672.02K

7,361.35%2.41M

55,408.62%991.38K

10,976.26%1.3M

1,232.60%124.31K

-116.01%-1.52K

108.96%32.35K

101.71%1.79K

108.87%11.73K

Change In working capital

-152.23%-490.04K

929.15%289.56K

26.47%803.8K

-111.38%-164.29K

-99.92%1.79K

157.23%938.16K

101.84%28.14K

139.38%635.57K

245.83%1.44M

633.32%2.36M

-Change in receivables

-1,809.76%-378.25K

-5,459.45%-140.36K

93.58%-93.22K

-8.88%-474.24K

-75.07%356.28K

102.19%22.12K

100.18%2.62K

-102.67%-1.45M

54.96%-435.56K

256.69%1.43M

-Change in inventory

----

105.05%3.01K

-Change in prepaid assets

-70.33%60.63K

73.78%-53.38K

-57.19%101.93K

1,588.08%74K

-97.35%27.2K

130.43%204.34K

-79.73%-203.62K

166.64%238.09K

-101.72%-4.97K

340.02%1.03M

-Change in payables and accrued expense

-127.64%-178.42K

110.92%483.31K

-61.49%712.88K

-88.38%219.95K

-274.82%-381.69K

1,436.53%645.48K

1,111.02%229.14K

460.48%1.85M

645.84%1.89M

71.31%-101.83K

-Change in other current liabilities

----

626.92%13.7K

715.38%16K

--0

----

---2.6K

--0

-Change in other working capital

----

--68.52K

---1

--0

----

Cash from discontinued investing activities

Operating cash flow

-12.70%-1.01M

68.41%-473.16K

42.75%-4.24M

-3.99%-479.46K

-164.53%-1.36M

73.76%-899.83K

49.98%-1.5M

2.62%-7.4M

81.74%-461.07K

76.82%-513.7K

Investing cash flow

Cash flow from continuing investing activities

79.08%-360.19K

285.11%154.17K

95.16%-73.78K

-113.62%-1.72M

-119.51%-83.29K

-87.85%-1.52M

Net PPE purchase and sale

----

82.29%-21.2K

--0

----

-583.84%-119.69K

---89

75.11%-4.36K

Net business purchase and sale

----

78.84%-338.99K

----

-135.27%-1.6M

----

Net investment purchase and sale

----

96.54%-52.58K

----

---1.52M

Cash from discontinued investing activities

Investing cash flow

----

79.08%-360.19K

285.11%154.17K

95.16%-73.78K

----

-113.62%-1.72M

-119.51%-83.29K

-87.85%-1.52M

Financing cash flow

Cash flow from continuing financing activities

2,849.68%868.54K

-69.36%676.17K

-2.37%3.92M

134.49%87.42K

174.49%1.66M

-100.86%-31.59K

2.21M

-59.84%4.01M

-105.96%-253.5K

-89.63%603.5K

Net issuance payments of debt

--0

-87.22%282.1K

32.18%462.62K

--110.11K

-620.71%-1.82M

---31.59K

--2.21M

227.98%350K

--0

269.00%350K

Net common stock issuance

----

-71.34%1.05M

--0

314.20%1.05M

----

-67.05%3.66M

-105.97%-253.5K

-96.31%253.5K

Proceeds from stock option exercised by employees

--737.5K

--394.07K

--2.41M

---22.69K

--2.43M

--0

----

Cash from discontinued financing activities

Financing cash flow

2,849.68%868.54K

-69.36%676.17K

-2.37%3.92M

134.49%87.42K

174.49%1.66M

-100.86%-31.59K

--2.21M

-59.84%4.01M

-105.96%-253.5K

-89.63%603.5K

Net cash flow

Beginning cash position

-63.22%659K

-48.50%716.78K

-78.80%1.39M

-43.10%1.12M

-79.38%742.19K

-47.80%1.79M

-78.80%1.39M

31.27%6.57M

-55.72%1.97M

117.21%3.6M

Current changes in cash

89.39%-145.56K

-71.37%203.01K

86.74%-677.07K

70.19%-237.87K

115.62%223.83K

-745.53%-1.37M

122.96%708.95K

-420.77%-5.11M

-137.02%-797.86K

-151.36%-1.43M

Effect of exchange rate changes

-28.85%229.32K

15.55%-260.78K

103.15%2.12K

-175.78%-166.29K

179.14%154.92K

802.48%322.3K

-583.95%-308.8K

-140.31%-67.34K

654.14%219.44K

-9,162.27%-195.75K

End cash Position

0.08%742.77K

-63.22%659K

-48.50%716.78K

-43.10%1.12M

-79.38%742.19K

-47.80%1.79M

-78.80%1.39M

-55.72%1.97M

Free cash flow

-12.70%-1.01M

68.41%-473.16K

43.38%-4.26M

-3.97%-479.46K

-166.40%-1.38M

73.93%-899.83K

51.49%-1.5M

1.28%-7.52M

81.73%-461.16K

76.81%-518.06K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-12.70%-1.01M	68.41%-473.16K	42.75%-4.24M	-3.99%-479.46K	-164.53%-1.36M	73.76%-899.83K	49.98%-1.5M	2.62%-7.4M	81.74%-461.07K	76.82%-513.7K
Net income from continuing operations	45.03%-1.27M	-109.83%-3.98M	33.12%-10.91M	26.02%-3.33M	10.82%-3.37M	-18.89%-2.32M	68.83%-1.9M	-35.53%-16.31M	34.78%-4.5M	-100.21%-3.78M
Operating gains losses	----	----	--221.89K	----	----	----	----	----	----	----
Depreciation and amortization	90.15%13.31K	-80.19%1.29K	19.88%28.53K	17.82%7.58K	15.43%7.46K	27.43%7K	20.00%6.49K	98.44%23.8K	96.91%6.44K	126.26%6.46K
Deferred tax	----	----	-86.62%115.67K	-83.11%151.39K	-184.55%-117.41K	----	----	4.93%864.8K	-11.39%896.05K	283.53%138.87K
Other non cash items	95.91%243.53K	44,282.51%672.02K	7,361.35%2.41M	55,408.62%991.38K	10,976.26%1.3M	1,232.60%124.31K	-116.01%-1.52K	108.96%32.35K	101.71%1.79K	108.87%11.73K
Change In working capital	-152.23%-490.04K	929.15%289.56K	26.47%803.8K	-111.38%-164.29K	-99.92%1.79K	157.23%938.16K	101.84%28.14K	139.38%635.57K	245.83%1.44M	633.32%2.36M
-Change in receivables	-1,809.76%-378.25K	-5,459.45%-140.36K	93.58%-93.22K	-8.88%-474.24K	-75.07%356.28K	102.19%22.12K	100.18%2.62K	-102.67%-1.45M	54.96%-435.56K	256.69%1.43M
-Change in inventory	----	----	----	----	----	----	----	----	----	105.05%3.01K
-Change in prepaid assets	-70.33%60.63K	73.78%-53.38K	-57.19%101.93K	1,588.08%74K	-97.35%27.2K	130.43%204.34K	-79.73%-203.62K	166.64%238.09K	-101.72%-4.97K	340.02%1.03M
-Change in payables and accrued expense	-127.64%-178.42K	110.92%483.31K	-61.49%712.88K	-88.38%219.95K	-274.82%-381.69K	1,436.53%645.48K	1,111.02%229.14K	460.48%1.85M	645.84%1.89M	71.31%-101.83K
-Change in other current liabilities	----	----	626.92%13.7K	715.38%16K	--0	----	----	---2.6K	---2.6K	--0
-Change in other working capital	----	----	--68.52K	---1	--0	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-12.70%-1.01M	68.41%-473.16K	42.75%-4.24M	-3.99%-479.46K	-164.53%-1.36M	73.76%-899.83K	49.98%-1.5M	2.62%-7.4M	81.74%-461.07K	76.82%-513.7K
Investing cash flow
Cash flow from continuing investing activities			79.08%-360.19K	285.11%154.17K	95.16%-73.78K			-113.62%-1.72M	-119.51%-83.29K	-87.85%-1.52M
Net PPE purchase and sale	----	----	82.29%-21.2K	--0	----	----	----	-583.84%-119.69K	---89	75.11%-4.36K
Net business purchase and sale	----	----	78.84%-338.99K	----	----	----	----	-135.27%-1.6M	----	----
Net investment purchase and sale	----	----	----	----	96.54%-52.58K	----	----	----	----	---1.52M
Cash from discontinued investing activities
Investing cash flow	----	----	79.08%-360.19K	285.11%154.17K	95.16%-73.78K	----	----	-113.62%-1.72M	-119.51%-83.29K	-87.85%-1.52M
Financing cash flow
Cash flow from continuing financing activities	2,849.68%868.54K	-69.36%676.17K	-2.37%3.92M	134.49%87.42K	174.49%1.66M	-100.86%-31.59K	2.21M	-59.84%4.01M	-105.96%-253.5K	-89.63%603.5K
Net issuance payments of debt	--0	-87.22%282.1K	32.18%462.62K	--110.11K	-620.71%-1.82M	---31.59K	--2.21M	227.98%350K	--0	269.00%350K
Net common stock issuance	----	----	-71.34%1.05M	--0	314.20%1.05M	----	----	-67.05%3.66M	-105.97%-253.5K	-96.31%253.5K
Proceeds from stock option exercised by employees	--737.5K	--394.07K	--2.41M	---22.69K	--2.43M	--0	--0	--0	--0	----
Cash from discontinued financing activities
Financing cash flow	2,849.68%868.54K	-69.36%676.17K	-2.37%3.92M	134.49%87.42K	174.49%1.66M	-100.86%-31.59K	--2.21M	-59.84%4.01M	-105.96%-253.5K	-89.63%603.5K
Net cash flow
Beginning cash position	-63.22%659K	-48.50%716.78K	-78.80%1.39M	-43.10%1.12M	-79.38%742.19K	-47.80%1.79M	-78.80%1.39M	31.27%6.57M	-55.72%1.97M	117.21%3.6M
Current changes in cash	89.39%-145.56K	-71.37%203.01K	86.74%-677.07K	70.19%-237.87K	115.62%223.83K	-745.53%-1.37M	122.96%708.95K	-420.77%-5.11M	-137.02%-797.86K	-151.36%-1.43M
Effect of exchange rate changes	-28.85%229.32K	15.55%-260.78K	103.15%2.12K	-175.78%-166.29K	179.14%154.92K	802.48%322.3K	-583.95%-308.8K	-140.31%-67.34K	654.14%219.44K	-9,162.27%-195.75K
End cash Position	0.08%742.77K	-63.22%659K	-48.50%716.78K	-48.50%716.78K	-43.10%1.12M	-79.38%742.19K	-47.80%1.79M	-78.80%1.39M	-78.80%1.39M	-55.72%1.97M
Free cash flow	-12.70%-1.01M	68.41%-473.16K	43.38%-4.26M	-3.97%-479.46K	-166.40%-1.38M	73.93%-899.83K	51.49%-1.5M	1.28%-7.52M	81.73%-461.16K	76.81%-518.06K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data